Coronavirus (No politics)

Imo, we ought to blame the unvaccinated people in this country for a variant that originated on a different continent.
I don't blame anybody..what happens to the unvaxxed is their fault, but I respect a persons right to flirt with death if they so choose...I just don't feel sorry for them.
 
Well, both the vaccinated and the unvaccinated are capable of contracting the virus and transmitting it to others. Therefore vaccination status is meaningless on that point and both are equally at fault.
Ok..can't argue with that. I don't think anybody outside of the Chinese are at fault.
 
You won't get a bad case or die...mortality will be way down amongst vaccinated.
Looks like that may not be the case. It has 9 mutations on the spike protein, which is what the vaccines produce. So we may be back to square one for everyone in the world 🥴. They’re saying it evolved in an AIDS patient in Africa. Or China released an update as a thanksgiving gift 🎁
 
Its gonna continue to mutate...that's what viruses do...generally to weaker variants....believe it or not it is not in a viruses intent to kill their host since they sorta need them to survive...I can now be called fully vaxxed again by CDC/Fauci J&J/Moderna wife Moderna x3
 
Its gonna continue to mutate...that's what viruses do...generally to weaker variants....believe it or not it is not in a viruses intent to kill their host since they sorta need them to survive...I can now be called fully vaxxed again by CDC/Fauci J&J/Moderna wife Moderna x3
Me too
I’m expecting to end up with a yearly flu and Covid shot
 
Merck updated the results of the clinical trial with molnupiravir which is their oral pill they are studying to treat covid. Apparently not as good as they initially reported and now only reduces hospitalization and death by 30% in at risk individuals (down from 50%). Kinda devious that they update the results on thanksgiving when no one is paying attention. Still though the drug is better than nothing.
Merck and Ridgeback Biotherapeutics Provide Update on Results from MOVe-OUT Study of Molnupiravir, an Investigational Oral Antiviral Medicine, in At Risk Adults With Mild-to-Moderate COVID-19 - Merck.com
 
  • Like
Reactions: MAD and VolnJC
Advertisement



Back
Top